The largest database of trusted experimental protocols

Platelia sars cov 2 total ab

Manufactured by Bio-Rad
Sourced in Germany

The Platelia SARS-CoV-2 Total Ab is an in vitro diagnostic test for the qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma samples. It is designed to aid in the diagnosis of COVID-19 infection.

Automatically generated - may contain errors

4 protocols using platelia sars cov 2 total ab

1

Contrivance of SARS-CoV-2 Antibody DBS Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 antibody positive and negative plasma used to contrive DBS specimens are described in Table 3. SARS-CoV-2 antibody positive plasma was collected from COVID-19 convalescent donors at Mount Sinai Hospital (Toronto, Canada). Plasma was tested for SARS-CoV-2 antibodies using the Platelia SARS-CoV-2 Total Ab (Bio-Rad, Hercules, California) or Anti-SARS-CoV-2 ELISA IgG (EUROIMMUN, Lübeck, Germany) kits. SARS-CoV-2 negative plasma was collected from healthy donors within the National Microbiology Laboratory (Winnipeg, Canada). To prepare plasma, blood was collected in EDTA Vacutainer tubes (Beckton Dickinson, Franklin Lates, NJ) and centrifuged at 1,500 RPM for 7 minutes. Plasma was tested using the Platelia SARS-CoV-2 Total Ab (Bio-Rad) or Anti-SARS-CoV-2 ELISA IgG (EUROIMMUN, Lübeck, Germany) kits to verify donors were negative for SARS-CoV-2 antibodies. All assays were performed according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

DBS Elution and Antibody Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DBS samples were punched using a 6 mm hole punch into a 96 deep well plate. One to four 6 mm (1/4 inch) punches were added to each well and eluted in DPBS buffer (pH 7.4) containing 0.5% BSA and 0.05% Tween-20 overnight at 4°C with agitation (400 RPM). For the Anti-SARS-CoV-2 ELISA IgG (EUROIMMUN) a single punch was eluted in 500 ul of Sample Buffer overnight without agitation and 100 μL of eluate was transferred to the assay plate. For Platelia SARS-CoV-2 Total Ab (Bio-Rad) assay, two punches were eluted in 130 μL of Sample Diluent overnight with gentle agitation (400 RPM), 75 μL of eluate was mixed with conjugate, and 100 μL of the eluate-conjugate mixture was transferred to the assay plate. Elution volumes were adjusted for all other assays according to manufacturer’s specifications or in-house developed protocols (Table 4). Afterwards, plates were incubated at room temperature for 30 minutes with agitation (400 RPM) and each DBS eluate was transferred to an individual 2.0 mL screw cap tube. Eluates were stored at -80°C until shipment on dry ice to each testing site.
+ Open protocol
+ Expand
3

Quantifying SARS-CoV-2 Antibody Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sera, collected at different time points for all participants, were aliquoted and
stored at –80°C to avoid repeated freeze-thaw cycles. Complement components and
potential infectious viruses in serum samples were heated-deactivated at 56°C
for 30 min immediately before use.
Titers of S protein antibodies and the presence of N protein antibodies were
determined using Ortho Anti-SARS-CoV-2 total immunoglobulin (Ig) (Vitros, Cat#
6199922) and Platelia SARS-CoV-2 Total Ab (Biorad, Cat# 72710), respectively. In
addition, the serum capacities of inhibiting RBD–ACE2 binding were determined
using SARS-CoV-2 surrogate virus neutralization kits (Genscript, Cat#
L00847).
+ Open protocol
+ Expand
4

SARS-CoV-2 Antibody Detection Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following tests were used for the detection of specific anti-SARS-CoV-2 antibodies in the intermediates and the FP:

SARS-CoV-2 Ab ELISA Test (Wantai, Beijing, China)—for simultaneous detection of three antibody isotypes (IgM, IgA, IgG) directed to the S1-RBD;

SARS-CoV-2 Ab IgM ELISA (Wantai, Beijing, China)—for detecting the IgM isotype of specific antibodies directed to the S1-RBD;

Anti-SARS-CoV-2 IgA ELISA (EUROIMMUN, Lübeck, Germany)—for semi-quantitative in vitro evaluation of anti-SARS-CoV-2 IgA antibodies directed to the S1 protein;

Anti-SARS-CoV-2 ELISA (IgG) (EUROIMMUN, Lübeck, Germany)—for semi-quantitative in vitro evaluation of anti-SARS-CoV-2 IgG antibodies directed to the S1 protein. The test was used in 2020, and since December 2020, anti-SARS-CoV-2 QuantiVac ELISA (IgG) (EUROIMMUN, Lübeck, Germany) quantitative test was in use;

iFlash–SARS-CoV-2 IgG—chemiluminescence test for semi-quantitative detection of anti-SARS-CoV-2 IgG antibodies (SHENZHEN YHLO BIOTECH CO., Shenzhen, China);

Bio-Rad Platelia SARS-CoV-2 Total Ab—for simultaneous detection of IgG, IgA, and IgM antibodies directed to the nucleocapsid (anti-N).

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!